Search companies, stocks, cryptocurrencies, and more...
- Overview
- Financial Statement
- Ratio
- Dividend
- Net Worth
- Financial Forecast
- Stock Splits
Tonix Pharmaceuticals Holding Corp.
TNXP | NASDAQ Capital Market
0.6116USD0.0416 %
Market Value Ratio
Annual
| Breakdown | 2024-12-22 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|
Price-to-Earnings ratio (P/E)
-0.2809
%377.09 -0.0589
%-51.64 -0.1218
%-91.38 -1.41
%15.41 -1.22
0
0
0
0
Price to Sales Ratio (P/S)
10.12
%1044.85 0.8843
0
0
0
0
0
0
0
Price-to-Cash Flow ratio (P/CF)
-0.5626
%735.46 -0.0673
%-53.60 -0.1451
%-91.59 -1.73
%31.22 -1.31
0
0
0
0
Price to Free Cash Flow Ratio (PFCF)
-1.67
%2571.49 -0.0625
%-35.79 -0.0973
%-91.72 -1.18
%5.20 -1.12
0
0
0
0
Price to Book (PB) Ratio
0.5120
%686.52 0.0651
%-5.24 0.0687
%-88.47 0.5960
%-18.19 0.7285
0
0
0
0
Dividend Yield
0
0
0.4679
0
0.0071
0
0
0
0
Payout Ratio
0
0
-0.0570
0
-0.0086
%-89.14 -0.0796
%-28.48 -0.1113
0
0
Price Earnings to Growth Ratio (PEG)
-0.0054
%-699.51 0.0009
%-55.53 0.0020
%-92.29 0.0261
0
0
0
0
0
Enterprise Value Multiplier
-1.19
%-1748.54 0.0725
%-92.37 0.9495
%84.97 0.5133
%117.63 0.2359
%-37.62 0.3781
%-60.32 0.9530
%-21.28 1.21
%147.77 0.4886
Price Fair Value
0.5120
%686.52 0.0651
%-5.24 0.0687
%-88.47 0.5960
%-18.19 0.7285
0
0
0
0
Efficiency Ratio
Annual
| Breakdown | 2024-12-22 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|
Receivables Turnover
2.81
%66.25 1.69
0
0
0
0
0
0
0
Inventory Turnover
1.32
%292.80 0.3351
%-102.40 -13.94
%16.64 -11.95
%80.41 -6.62
%-76.77 -28.51
0
0
0
Fixed Asset Turnover
0.2603
%217.86 0.0819
0
0
0
0
0
0
0
Operating Cycle
407.01
%-68.81 1.3 K
0
0
0
0
0
0
0
Cash Conversion Cycle (CCC)
269.43
%-73.42 1.01 K
0
0
0
0
0
0
0
Days of Sales Outstanding (DSO)
129.73
%-39.85 215.67
0
0
0
0
0
0
0
Days of Inventory Outstanding (DIO)
277.28
%-74.54 1.09 K
%-4258.60 -26.19
%-14.27 -30.55
%-44.57 -55.11
%330.56 -12.8
0
0
0
Days of Payables Outstanding (DPO)
137.57
%-52.75 291.17
%1008.30 26.27
%-49.97 52.52
%58.06 33.23
%-14.52 38.87
%99.65 19.47
%-12.37 22.22
%172.03 8.17
Payables Turnover
2.65
%111.64 1.25
%-90.98 13.89
%99.90 6.95
%-36.73 10.99
%16.99 9.39
%-49.91 18.75
%14.12 16.43
%-63.24 44.69
Cash Flow Ratio
Annual
| Breakdown | 2024-12-22 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|
Operating Cash Flow Sales Ratio
-5.98
%-54.45 -13.13
0
0
0
0
0
0
0
Free Cash Flow Operating Cash Flow Ratio
1.01
%-5.91 1.08
%-27.74 1.49
%1.62 1.47
%24.73 1.18
%17.56 1
%0.04 1
%-0.00 1
%-0.15 1
Cash Flow Coverage Ratios
-13.06
%14.07 -11.45
0
0
0
0
0
0
0
Short Term Coverage Ratios
0
%-100.00 -43.41
0
0
0
0
0
0
0
Capital Expenditure Coverage Ratio
-143.42
%1010.05 -12.92
%534.41 -2.04
%-4.83 -2.14
%-62.26 -5.67
%-99.64 -1.57 K
%-60.71 -4 K
%4.43 -3.83 K
%576.64 -565.38
Dividend Paid and Capex Coverage Ratio
-143.42
%1010.05 -12.92
%622.15 -1.79
%-16.40 -2.14
%-60.28 -5.39
%-49.71 -10.71
%46.21 -7.33
%-99.81 -3.83 K
%576.64 -565.38
Cash per Share
0.4545
%-99.03 46.85
%-92.89 658.63
%-79.01 3.14 K
%-39.82 5.21 K
0
0
0
0
Free Cashflow per Share
-1.1
%-99.47 -206.39
%-74.23 -800.9
%-58.87 -1.95 K
%-49.63 -3.87 K
0
0
0
0
Operating Cashflow per Share
-1.09
%-99.43 -191.56
%-64.34 -537.14
%-59.52 -1.33 K
%-59.61 -3.29 K
0
0
0
0
Finn Scope